Robin LaChapelle - 11 Jul 2025 Form 4 Insider Report for ArriVent BioPharma, Inc. (AVBP)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Jul 2025, 07:00:15 UTC
Prior SEC filing
14 Feb 2025
Next SEC filing
04 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ James Kastenmayer, Attorney-in-Fact for Robin LaChapelle
Filing notes and source

Key filing fact

Robin LaChapelle filed Form 4 for ArriVent BioPharma, Inc. (AVBP) on 15 Jul 2025.

Key facts

  • This page summarizes Robin LaChapelle's Form 4 filing for ArriVent BioPharma, Inc. (AVBP).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 15 Jul 2025, 07:00.

Change

  • Previous filing in this sequence was filed on 14 Feb 2025.
  • Current net transaction value: +$25,429.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002009136 Primary reporting owner

LaChapelle Robin

Relationship
Chief Operating Officer
Address
C/O ARRIVENT BIOPHARMA, INC., 18 CAMPUS BOULEVARD, SUITE 100, NEWTOWN SQUARE
Signature
By: /s/ James Kastenmayer, Attorney-in-Fact for Robin LaChapelle
Signature date
15 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVBP transaction

Common Stock

Options Exercise

Transaction value
$4,674
Shares
+2,050
Change %
+1.6%
Price
$2.28
Shares after
126,633
Date
11 Jul 2025
Ownership
Direct
AVBP transaction

Common Stock

Options Exercise

Transaction value
$5,928
Shares
+2,600
Change %
+2.1%
Price
$2.28
Shares after
129,233
Date
11 Jul 2025
Ownership
Direct
AVBP transaction

Common Stock

Options Exercise

Transaction value
$14,827
Shares
+6,503
Change %
+5%
Price
$2.28
Shares after
135,736
Date
11 Jul 2025
Ownership
Direct
AVBP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
394,477
Date
11 Jul 2025
Ownership
Held by The MAKS Yao Trust
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVBP transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-2,050
Change %
-83%
Price
$0.000000
Shares after
410
Date
11 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,050
Exercise price
$2.28
Footnotes
F2
AVBP transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-2,600
Change %
-17%
Price
$0.000000
Shares after
12,873
Date
11 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,600
Exercise price
$2.28
Footnotes
F3
AVBP transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-6,503
Change %
-51%
Price
$0.000000
Shares after
6,370
Date
11 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,503
Exercise price
$2.28
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person is the Trustee of The MAKS Yao Trust and may be deemed to have shared voting and investment power over the shares held by The MAKS Yao Trust. The Reporting Person does not have a pecuniary interest in and disclaims beneficial ownership of the shares held by The MAKS Yao Trust.

Footnote F2

The shares underlying this option vested as to 25% on September 8, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Footnote F3

The shares underlying this option vested as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .